Efficacy and Tolerability of a Single-Pill Combination of Amlodipine/Valsartan in Asian Hypertensive Patients Not Adequately Controlled with Valsartan Monotherapy

REFERENCES

• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003;289:2560–2572.
   PubMed Web of Science ®Google Scholar
• Kearney PM, Whelton M, Reynolds K, Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217–223.
   PubMed Web of Science ®Google Scholar
• Chinese Guidelines for Prevention and Treatment of Hypertension. (revised ed. 2005). Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. People's Medical Publishing House, 2005.
   Google Scholar
• Kjeldsen SE, Aksnes TA, Sierra ADL, Ruilope LM. Amlodipine and Valsartan: Calcium channel blockers/angiotensin II receptor blockers combination for hypertension. Drug Eval 2007;4:31–40.
   Google Scholar
• Sica DA. Rationale for fixed-dose combinations in the treatment of hypertension: The cycle repeats. Drugs 2002;62:443–462.
   PubMed Web of Science ®Google Scholar
• Liu L. Cardiovascular diseases in China. Biochem Cell Biol 2007;85(2):157–163.
   PubMed Web of Science ®Google Scholar
• Gu D, Kelly TN, Wu X, Chen J, Duan X, Huang JF, Chen JC, Whelton PK, He J. Blood pressure and risk of cardiovascular disease in Chinese men and women. Am J Hypertens 2008;21 (3):265–272.
   PubMed Web of Science ®Google Scholar
• Mancia G, Laurent S, Agabiti-Rosei E,Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A; European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009;27(11): 2121–2158.
   Web of Science ®Google Scholar
• Wong MC, Jiang JY, Gibbs T, Griffiths SM. Factors associated with antihypertensive drug discontinuation among Chinese patients: a cohort study. Am J Hypertens 2009;22(7):802–810.
   PubMed Web of Science ®Google Scholar
• Epstein BJ, Vogel K, Palmer BF. Dihydropyridine calcium channel antagonists in the management of hypertension. Drugs 2007;67(9):1309–1327.
   PubMed Web of Science ®Google Scholar
• Philipp T, Smith TR, Glazer R, Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild-to-moderate essential hypertension. Clin Ther 2007;29:563–580.
   PubMed Web of Science ®Google Scholar
• Sinkiewicz W, Glazer RD, Kavoliuniene A, Miglinas M, Prak H, Wernsing M, Yen J. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy. Curr Med Res Opin 2009;25(2):315–324.
   PubMed Web of Science ®Google Scholar
• Brachmann J, Ansari A, Mahla G, Handrock R, Klebs S. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy. Adv Ther 2008;25(5):399–411.
   PubMed Web of Science ®Google Scholar
• Schrader J, Salvetti A, Calvo C, Akpinar E, Keeling L, Weisskopf M, Brunel P. The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg. Int J Clin Pract 2009;63(2):217–225.
   PubMed Web of Science ®Google Scholar
• Allemann Y, Fraile B, Lambert M, Barbier M, Ferber P, Izzo JL Jr. Jr. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study. J Clin Hypertens (Greenwich) 2008;10 (3):185–194.
   PubMed Web of Science ®Google Scholar
• Zhu J-R, Fujita T, Shimamoto K, Wu Z-S, Chung N-S, Park J-B, Lee Y-T, Liau C-S, Chen M-F. Implication of clinical studies for the Asian population: focus on Chinese/Asian population. Int J Clin Pract 2006;60 (suppl. 150):14–16.
   Web of Science ®Google Scholar
• Mochizuki M, Dahlöf B, Shimizu M, Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet 2007;369:1431–1439.
   PubMed Web of Science ®Google Scholar
• Sawada T, Yamada H, Dahlöf B, Matsubara H, for the KYOTO HEART Study Group. Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study. Eur Heart J 2009;30(20):2461–2469.
   PubMed Web of Science ®Google Scholar
• Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359(23):2417–2428.
   PubMed Web of Science ®Google Scholar
• Elliott WJ. Is fixed combination therapy appropriate for initial hypertension treatment? Curt Hypertens Rep 2002;4:278–285.
   PubMed Web of Science ®Google Scholar
• Payne KA, Esmonde-White S. Observational studies of antihypertensive medication use and compliance: Is drug choice a factor in treatment adherence? Curr Hypertens Rep 2000;2:515–524.
   PubMedGoogle Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353:487–497.
   PubMed Web of Science ®Google Scholar